153 related articles for article (PubMed ID: 18281541)
21. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
White KL; Vierkant RA; Fogarty ZC; Charbonneau B; Block MS; Pharoah PD; Chenevix-Trench G; ; Rossing MA; Cramer DW; Pearce CL; Schildkraut JM; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean Y; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton L; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh C; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubinski J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Denberg D; Terry KL; Vitonis AF; Doherty JA; Johnatty SE; Defazio A; Song H; Tyrer J; Sellers TA; Phelan CM; Kalli KR; Cunningham JM; Fridley BL; Goode EL
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):987-92. PubMed ID: 23513043
[TBL] [Abstract][Full Text] [Related]
22. A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival.
Belotte J; Fletcher NM; Saed MG; Abusamaan MS; Dyson G; Diamond MP; Saed GM
PLoS One; 2015; 10(8):e0135739. PubMed ID: 26301412
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
24. Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
Song H; Ramus SJ; Kjaer SK; Hogdall E; Dicioccio RA; Whittemore AS; McGuire V; Hogdall C; Jacobs IJ; Easton DF; Ponder BA; Dunning AM; Gayther SA; Pharoah PD
PLoS One; 2007 Mar; 2(3):e268. PubMed ID: 17342202
[TBL] [Abstract][Full Text] [Related]
25. STK15 polymorphisms and association with risk of invasive ovarian cancer.
Dicioccio RA; Song H; Waterfall C; Kimura MT; Nagase H; McGuire V; Hogdall E; Shah MN; Luben RN; Easton DF; Jacobs IJ; Ponder BA; Whittemore AS; Gayther SA; Pharoah PD; Kruger-Kjaer S
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1589-94. PubMed ID: 15466974
[TBL] [Abstract][Full Text] [Related]
26. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract][Full Text] [Related]
27. Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.
Bartel F; Jung J; Böhnke A; Gradhand E; Zeng K; Thomssen C; Hauptmann S
Clin Cancer Res; 2008 Jan; 14(1):89-96. PubMed ID: 18172257
[TBL] [Abstract][Full Text] [Related]
28. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients.
Andrusiewicz M; Skibińska I; Gąsiorowska E; Białas P; Kotwicka M
Biomed Pharmacother; 2017 Jun; 90():139-146. PubMed ID: 28355589
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.
Cunningham JM; Vierkant RA; Sellers TA; Phelan C; Rider DN; Liebow M; Schildkraut J; Berchuck A; Couch FJ; Wang X; Fridley BL; ; Gentry-Maharaj A; Menon U; Hogdall E; Kjaer S; Whittemore A; DiCioccio R; Song H; Gayther SA; Ramus SJ; Pharaoh PD; Goode EL
Br J Cancer; 2009 Oct; 101(8):1461-8. PubMed ID: 19738611
[TBL] [Abstract][Full Text] [Related]
31. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
[TBL] [Abstract][Full Text] [Related]
32. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy.
Tecza K; Pamula-Pilat J; Kolosza Z; Radlak N; Grzybowska E
J Exp Clin Cancer Res; 2015 Jan; 34(1):2. PubMed ID: 25591549
[TBL] [Abstract][Full Text] [Related]
34. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis.
Xu Y; Liu Y; Zhou R; Meng F; Gao Y; Yang S; Li X; Yang M; Lou G
Jpn J Clin Oncol; 2012 May; 42(5):413-9. PubMed ID: 22412199
[TBL] [Abstract][Full Text] [Related]
35. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.
Castillejo A; Rothman N; Murta-Nascimento C; Malats N; García-Closas M; Gómez-Martínez A; Lloreta J; Tardón A; Serra C; García-Closas R; Chanock S; Silverman DT; Dosemeci M; Kogevinas M; Carrato A; Soto JL; Real FX
Int J Cancer; 2009 Feb; 124(3):608-13. PubMed ID: 19004027
[TBL] [Abstract][Full Text] [Related]
36. Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.
Dixon SC; Ibiebele TI; Protani MM; Beesley J; deFazio A; Crandon AJ; Gard GB; Rome RM; Webb PM; Nagle CM;
Gynecol Oncol; 2014 Mar; 132(3):566-72. PubMed ID: 24368279
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
38. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
39. Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.
Braun R; Finney R; Yan C; Chen QR; Hu Y; Edmonson M; Meerzaman D; Buetow K
PLoS One; 2013; 8(3):e55037. PubMed ID: 23555554
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer.
Smolarz B; Michalska MM; Samulak D; Romanowicz H; Wójcik L
Pathol Oncol Res; 2019 Oct; 25(4):1607-1614. PubMed ID: 30712190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]